OncBioMune Pharmaceuticals, Inc Uncategorized Contracts & Agreements
31 Contracts & Agreements
- Offer Letter between the Company and Faith Zaslavsky, dated December 5, 2022 (Filed With SEC on December 9, 2022)
- Form of 10% Original Issue Discount Senior Secured Convertible Debentures (Exchanged Debentures) (Filed With SEC on December 1, 2022)
- Form of 10% Original Issue Discount Senior Secured Convertible Debentures (Filed With SEC on December 1, 2022)
- Engagement Letter, by and between Carter, Terry & Company and Theralink Technologies, Inc., dated December 15, 2021, as amended (Filed With SEC on February 3, 2022)
- Warrants Agreement between Cavalry I LP and OncBioMune, Inc, dated November 13, 2018 (Filed With SEC on November 14, 2018)
- Form of Warrants issued September 24, 2018 (Filed With SEC on November 14, 2018)
- ForbearanceAgreement (Filed With SEC on June 6, 2017)
- NON-QUALIFIEDSTOCK OPTION AGREEMENT FOR DIRECTORS (Filed With SEC on April 21, 2017)
- FORMOF NON-QUALIFIEDSTOCK OPTION AGREEMENT (Filed With SEC on March 13, 2017)
- FORMOF (Filed With SEC on March 13, 2017)
- STOCKHOLDERS’AGREEMENT datedas of March10, 2017 among ONCBIOMUNEPHARMACEUTICALS, INC. and THESTOCKHOLDERS PARTY HERETO (Filed With SEC on March 13, 2017)
- Representations (Filed With SEC on March 13, 2017)
- PARTIES (Filed With SEC on March 13, 2017)
- AMENDEDAND RESTATED SECURITIESPURCHASE AGREEMENT (Filed With SEC on November 28, 2016)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on November 21, 2016)
- Account (Filed With SEC on May 16, 2016)
- SABRCapital Management LLC 335 Madison Avenue, Suite 1100, New York, New York 10017 (Filed With SEC on May 16, 2016)
- EMPLOYMENTAGREEMENT (Filed With SEC on February 5, 2016)
- PURCHASEAGREEMENT (Filed With SEC on November 20, 2015)
- PURCHASEAGREEMENT (Filed With SEC on October 26, 2015)
- DEBTSETTLEMENT AGREEMENT (Filed With SEC on June 24, 2015)
- DEBTSETTLEMENT AGREEMENT (Filed With SEC on March 16, 2015)
- Co-Promotion Agreement dated February 21, 2012 with Apricus Biosciences, Inc. (portions of the exhibit have been omitted pursuant to a request for confidential treatment) (Filed With SEC on May 18, 2012)
- Form of independent contractor agreement (Filed With SEC on September 30, 2011)
- Co-promotion agreement with Bi-Coastal Pharmaceuticals effective September 12, 2011 (portions of the exhibit have been omitted pursuant to a request for confidential treatment) (Filed With SEC on September 14, 2011)
- Cancellation Agreement dated February 9, 2011 with David Tousley (Filed With SEC on February 10, 2011)
- Cancellation Agreement dated February 9, 2011 with Cameron Durrant (Filed With SEC on February 10, 2011)
- Lock-up Agreement dated February 9, 2011 with David Tousley (Filed With SEC on February 10, 2011)
- Lock-up Agreement dated February 9, 2011 with Cameron Durrant (Filed With SEC on February 10, 2011)
- Letter of Intent with Granisol Oral Solution (Filed With SEC on June 28, 2010)
- SHAREEXCHANGE AGREEMENT Dated June22, 2015 byand among QUINTMEDIA, INC., a Nevada Corporation asthe Acquiror and Parent. and ONCBIOMUNE,INC., aLouisiana corporation and... (Filed With SEC on June 24, 2015)
